BIDU three-lens brief
Evidence-based stock research on BIDU. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both. · Trading at 4% of its 52-week range — deep in the lower band.
- Trading at 4% of its 52-week range — deep in the lower band.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- P/E of 80 — priced for high growth; little margin of safety.
- Analyst mean target $133.12 — 67% above current (30 analysts).
- Negative free cash flow last quarterly (-$2.10B).
BIDU closed at $79.76 (+0.06%) as of 2026-11-12. Market cap: $27.15B. P/E (trailing) 80.0. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $133.12 — 67% above current (30 analysts).. Concerns: trading at 4% of its 52-week range — deep in the lower band.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $31.32B, net income $2.32B, free cash flow -$2.10B. Watching for: 2026-11-16 earnings release (4 days out).
Why three lenses on BIDU, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BIDU across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/BIDU" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BIDU brief"></iframe>